Persistently Elevated Plasma Concentrations of RIPK3, MLKL, HMGB1, and RIPK1 in Patients with COVID-19 in the Intensive Care Unit.

Ruskowski, Katharina; Neb, Holger; Talbot, Steven R; Choorapoikayil, Suma; Adam, Elisabeth H; von Knethen, Andreas; Zacharowski, Kai; Heinicke, Ulrike

Ruskowski, Katharina; Neb, Holger; Talbot, Steven R; Choorapoikayil, Suma; Adam, Elisabeth H; von Knethen, Andreas; Zacharowski, Kai; Heinicke, Ulrike.

Ruskowski K; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy Frankfurt am Main, Germany.
Neb H; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy Frankfurt am Main, Germany.
Talbot SR; Institute for Laboratory Animal Science Hannover, Germany.
Choorapoikayil S; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy Frankfurt am Main, Germany.
Adam EH; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy Frankfurt am Main, Germany.
von Knethen A; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy Frankfurt am Main, Germany.
Zacharowski K; Fraunhofer Institute for Translational Medicine and Pharmacology Frankfurt am Main, Germany.
Heinicke U; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy Frankfurt am Main, Germany.

Am J Respir Cell Mol Biol ; 67(3): 405-408, 2022 09.

Article in English | MEDLINE | ID: covidwho-2009248

Subject(s)

COVID-19; HMGB1 Protein; Humans; Intensive Care Units; Protein Kinases/metabolism; Receptor-Interacting Protein Serine-Threonine Kinases/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: HMGB1 Protein / COVID-19 Limits: Humans Language: English Journal: Am J Respir Cell Mol Biol Journal subject: Molecular Biology Year: 2022 Document Type: Article Affiliation country: Rcmb.2022-0039LE

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google